MedTrace Logo

The Long-term Effect of Daily Jarlsberg Cheese Intake in Patient With Osteopenia

NCT06358443 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2025-05-09

No results posted yet for this study

Summary

Aim: To estimate the effect of daily optimal efficacy dose (OED) of Jarlsberg cheese in patients with Osteopeni (OP).

Study population: Post-menopausal women and men above 55 years of age in risk of Osteoporosis Treatment: Daily OED Jarlsberg cheese + vitamin D and Calcium tablets. Design: An open and one-armed observational study. Main variables: Bone Mineral Density (BMD), Bone turnover markers (BTMs), Osteocalcin and K2 vitameres.

Study Procedure: Prior to inclusion in this study, all the patients have undergone 32 days of daily OED intake of Jarlsberg cheese + vitamin D and caicium tablets. Thid is the baseline of this observational study. The duration of this study is 12 months with clinical examination and bloodsampling after 6 and 12 months.

Sample size: At least 16 patients will be included

Conditions

Interventions

DIETARY_SUPPLEMENT

Jarlsberg cheese

Jarlsberg cheese + Vitamin D ampulles + Calcium

Sponsors & Collaborators

  • Tine

    collaborator INDUSTRY

  • Meddoc

    lead OTHER

Principal Investigators

  • Anne C Whist, PhD · Tine

Study Design

Allocation
NA
Purpose
PREVENTION
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-06-03
Primary Completion
2024-10-18
Completion
2024-11-04

Countries

  • Norway

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06358443 on ClinicalTrials.gov